Subcutaneous methotrexate outcome in patients with psoriasis
Methotrexate is one of the most commonly used systemic drugs for the treatment of moderate to severe psoriasis; however, high-quality evidence for its use is sparse and limited to use of oral dosing. Authors Richard B Warren el al aimed to assess the effect of an intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis. The study entitled An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaq...

http://speciality.medicaldialogues.in/subcutaneous-methotrexate-outcome-in-patients-with-psoriasis-lancet-study/
Like
Comment
Share